文献速递其他结缔组织病

系统性硬化症中的舒张功能障碍:危险因素及对死亡率的影响

Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on Mortality.
PubMed 文献 · Arthritis Rheumatol · 2022-03-30

在约翰斯·霍普金斯硬皮病中心队列806例系统性硬化症患者中,18.6%存在舒张功能障碍;年龄、冠心病、肥胖、病程长、一氧化碳弥散量≤预计值60%及硬皮病肾危象史与舒张功能障碍风险升高独立相关,抗Scl-70阳性及严重胃肠道病变与风险降低相关;舒张功能障碍与死亡风险升高独立相关(HR 1.69)。

要点

  • 系统性硬化症患者中舒张功能障碍患病率为18.6%。
  • 冠心病(OR 3.69)和肥胖(OR 4.74)是与舒张功能障碍独立相关的可干预危险因素。
  • 舒张功能障碍与死亡风险升高独立相关(HR 1.69,95%CI 1.07-2.68)。

核心结论

  • 在系统性硬化症患者中,舒张功能障碍与死亡风险升高独立相关。
  • 作者认为,包括冠心病和肥胖在内的可干预危险因素应在系统性硬化症患者中加以处理以降低死亡风险。

研究设计与样本

  • 纳入2006年11月1日至2017年11月1日期间登记于约翰斯·霍普金斯硬皮病中心队列、在本系统内至少有一次可分析二维超声心动图的系统性硬化症患者,共806例。
  • 舒张功能障碍危险因素及系统性硬化症疾病特征为前瞻性获取,舒张功能障碍的有无依据最近一次二维超声心动图判定。
  • 采用逻辑回归模型检验临床危险因素与舒张功能障碍的关联,采用Cox比例风险模型评估生存。

主要发现

  • 18.6%的参与者存在舒张功能障碍。
  • 参与者多数为女性(84%),中位年龄58.4岁(四分位距48.8-68.1)。
  • 年龄较大(OR 1.12,95%CI 1.09-1.15,P<0.001)、冠心病(OR 3.69,95%CI 1.52-8.97,P=0.004)、肥胖(OR 4.74,95%CI 2.57-8.74,P<0.001)、系统性硬化症病程较长(OR 1.04,95%CI 1.01-1.06,P=0.004)、一氧化碳弥散量≤预计值60%(OR 2.41,95%CI 1.40-4.16,P=0.002)及硬皮病肾危象史(OR 3.18,95%CI 1.12-9.07,P=0.031)均与舒张功能障碍风险升高独立相关。
  • 抗Scl-70阳性(OR 0.49,95%CI 0.26-0.93,P=0.03)及严重胃肠道病变(OR 0.48,95%CI 0.30-0.79,P=0.004)与舒张功能障碍风险降低相关。
  • 舒张功能障碍的存在与死亡风险升高独立相关(HR 1.69,95%CI 1.07-2.68,P=0.027)。

临床怎么用

  • 作者认为,包括冠心病和肥胖在内的可干预危险因素应在系统性硬化症患者中加以处理以降低死亡风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the independent risk factors for diastolic dysfunction (DD) in patients with systemic sclerosis (SSc) and to evaluate the impact of DD on mortality. METHODS: SSc patients enrolled in the Johns Hopkins Scleroderma Center Cohort between November 1, 2006 and November 1, 2017 with ≥1 analyzable 2-dimensional (2-D) echocardiogram in our system were included (n = 806). DD risk factors and SSc disease characteristics were prospectively obtained, and the presence or absence of DD was determined using the most recent 2-D echocardiogram. Logistic regression models examined associations between clinical risk factors and DD, and Cox proportional hazards models were used to assess survival. RESULTS: DD was present in 18.6% of participants. The majority of participants were female (84%) with a median age of 58.4 years (interquartile range 48.8-68.1). Older age (odds ratio [OR] 1.12 [95% confidence interval (95% CI) 1.09-1.15], P < 0.001), coronary artery disease (OR 3.69 [95% CI 1.52-8.97], P = 0.004), obesity (OR 4.74 [95% CI 2.57-8.74], P < 0.001), longer SSc disease duration (OR 1.04 [95% CI 1.01-1.06], P = 0.004), diffusing capacity for carbon monoxide ≤60% of predicted (OR 2.41 [95% CI 1.40-4.16], P = 0.002), and history of scleroderma renal crisis (OR 3.18 [95% CI 1.12-9.07], P = 0.031) were all independently associated with an increased risk of DD. Anti-Scl-70 positivity (OR 0.49 [95% CI 0.26-0.93], P = 0.03) and severe gastrointestinal disease (OR 0.48 [95% CI 0.30-0.79], P = 0.004) were associated with a reduced risk of DD. The presence of DD was independently associated with an increase in the risk of mortality (hazard ratio 1.69 [95% CI 1.07-2.68], P = 0.027). CONCLUSION: DD is independently associated with an increased risk of mortality in patients with SSc. Potentially modifiable risk factors, including coronary artery disease and obesity, should be addressed in patients with SSc to reduce mortality risk.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Hinze AM, Perin J, Woods A, et al. Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on Mortality. Arthritis Rheumatol. 2022. PMID: 34927390. doi:10.1002/art.42054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。